Details

Autor(en) / Beteiligte

• Wollman, Yoram
• Westphal, Gabriela
• Blum, Miriam
• Simantov, Rabi
• Blumberg, Shmaryahu
• Peer, Gari
• Chernihovsky, Tamara
• Friedrich, Eckhard
• Iaina, Adrian

Titel

The effect of human recombinant erythropoietin on the growth of a human neuroblastoma cell line

Ist Teil von

• Life sciences (1973), 1996, Vol.59 (4), p.315-322

Ort / Verlag

Netherlands: Elsevier Inc

Erscheinungsjahr

1996

Quelle

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Beschreibungen/Notizen

• Erythropoietin is a growth factor. Cancer can be described as disturbance of the fine balance of positive and negative growth control mechanisms. The effect of human recombinant erythropoietin (EPO) was studied on the cell growth and differentiation of a human neuroblastoma cell line (h-NMB). Cell growth curves, trypan blue staining and thymidine uptake were used to assess cell proliferation and death. To assess cell differentiation, neutral endopeptidase (cell membrane enzyme marker), creatine kinase (cytosolic enzyme marker), dopamine uptake (dopamine transporter marker) and cell morphology were determined. Specific EPO receptor mRNA, by RT-PCR technique, was demonstrated. The incubation of erythropoietin with the tumor cell line resulted in inhibition of cell proliferation as evidenced in a diminished cell growth. EPO was shown to have induced a differentiation process as seen from the two different enzymatic markers, membranal and cytosolic, and from the cells dopamine uptake studies. However, the morphological changes did not document a full differentiation effect. EPO specific antibodies blocked the effects of EPO on cell proliferation and creatine kinase activity. In this study, EPO did not produce any sign of proliferation in the nervous tumor cell line used.